Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... retrospective chart review of patients with ovarian cancer Who Underwent BRCA1/BRCA2 genetic testing." "Thirty-three percent of our sample (n = 100) were seen ...
2009 NOV 9 ... distribution has a significant implication for cell fate determination. BCCIP is a BRCA2 and CDKN1A Interacting Protein. Previous reports showed that BCCIP enhances the p21 ...
2009 NOV 16 ... "Discovery of mutations in the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 can have emotional consequences for both the tested individual and his or her relatives. ...
2009 NOV 9 ... ovarian cancer. Lymphocyte specimens from peripheral blood were processed for BRCA1 and BRCA2 by direct sequencing. Sixteen percent (54/337) of patients had a strong family history. ...
2009 NOV 23 ... coding regions and splice junctions of both genes, a nonpreviously reported mutation in BRCA2 was detected in the index case. Direct mutation detection was performed with their ...
2009 NOV 2 ... According to recent research from Bangalore, India, "Mutations in the BRCA1 and BRCA2 genes profoundly increase the risk of developing breast and/or ovarian cancer among ...
2009 NOV 23 ... multiple sisters affected. Investigations. At 58 years of age, the patient underwent BRCA2 germline testing and was found to be a mutation carrier. Following post-test counseling, ...
2009 NOV 9 ... of various FA proteins is controlled by distinct mechanisms. BRCA-related FA proteins (BRCA2, FANCJ/BACH1, and FANCN/PALB2), but not FA core and I/D2 complexes, require replication ...
2009 NOV 16 ... in 'Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers' have been presented. According to a study from Cambridge, the United ...
2009 NOV 16 ... University of Sheffield. The researchers concluded: "In addition, BRCA2-deficient cells are sensitive to As[III] and we suggest that As[III] could be exploited ...
2009 NOV 2 ... with genetic counseling and testing for the cancer predisposition genes BRCA1 and BRCA2 (BRCA1/2) has become an integral element of comprehensive patient evaluation and cancer ...
2009 NOV 9 ... for FOXP1 was performed in 126 familial breast carcinomas comprising 35 BRCA1, 34 BRCA2 and 57 BRCAX. Nuclear FOXP1 expression ranged from focal weak to widespread strong ...
2009 NOV 2 ... According to recent research from Florence, Italy, "Germline mutations in the BRCA1 and BRCA2 tumour-suppressor genes predispose to early-onset breast and ovarian cancer. Although ...
2009 NOV 16 ... 2008. We screened all 564 patients for nine founder mutations: four in BRCA1, three in BRCA2 and one each in PALB2 and CHEK2. We also studied 6433 DNA samples from newborn infants ...
2009 NOV 2 ... exist that can decrease the morbidity and mortality associated with having a BRCA1 or BRCA2 mutation. Unfortunately, the task of identifying these patients at high risk is a ...
2009 NOV 9 ... to molecular changes and immunophenotype. Invasive breast cancers in germline BRCA1 and BRCA2 mutation carriers have a distinct ''basal'' and ''luminal'' immunophenotype, ...
2009 NOV 16 ... St., New York, NY 10013, USA. Keywords: United States, Chapel Hill, BRCA1, BRCA2, Breast Cancer, Breast Carcinoma, Familial Cancer, Genetic Counseling, Hereditary, ...
